Elan researches, develops and commercializes pharmaceutical products for neurodegenerative diseases.
Business Model:
Revenue: $119.6M
Employees: 201-500
Elan Corporation was acquired by
Perrigo.
The acquisition happend on 2013-08-05.
Details of the transaction were not public
Address: Treasury Building
City: Dublin
State: county dublin
Zip:
Country: IE
Elan researches, develops and commercializes pharmaceutical products for neurodegenerative diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NYSE
Ticker Symbol:
ELN
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2018 | Medikabazaar | Series A | 0 |
3/2011 | Proteostasis Therapeutics | Venture Round | 0 |
11/2019 | Medikabazaar | Series B | 0 |
5/2013 | NewBridge Pharmaceuticals | Series C | 0 |
11/2019 | Medikabazaar | Series B | 0 |
10/2018 | Medikabazaar | Series A | 0 |
5/2013 | NewBridge Pharmaceuticals | Series C | 0 |
3/2011 | Proteostasis Therapeutics | Venture Round | 0 |
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors |
---|
Announced Date | Name | Price |
---|---|---|
3/2000 | Liposome Company | |
3/1996 | Athena Neurosciences |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|